- Home
- SGMO vs WALD Comparison
SGMO vs WALD Comparison
Compare SGMO & WALD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SGMO | WALD |
|---|---|---|
| Founded | 1995 | 1988 |
| Country | United States | United Kingdom |
| Employees | N/A | 364 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Package Goods/Cosmetics |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 141.2M | 130.8M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | SGMO | WALD |
|---|---|---|
| Price | $0.13 | $0.97 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 3 |
| Target Price | ★ $7.00 | $2.00 |
| AVG Volume (30 Days) | ★ 9.1M | 1.2M |
| Earning Date | 05-07-2026 | 03-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.20 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $36,567,000.00 | N/A |
| Revenue This Year | $107.15 | $9.89 |
| Revenue Next Year | $76.44 | $4.31 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 88.60 | N/A |
| 52 Week Low | $0.12 | $0.72 |
| 52 Week High | $0.77 | $3.22 |
Technical Indicators
Market Signals| Indicator | SGMO | WALD |
|---|---|---|
| Relative Strength Index (RSI) | 25.62 | 44.33 |
| Support Level | N/A | $0.86 |
| Resistance Level | $0.55 | $2.06 |
| Average True Range (ATR) | 0.03 | 0.11 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 8.19 | 59.75 |
Price Performance
Historical ComparisonAbout SGMO Sangamo Therapeutics Inc.
Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases. Its pipeline products include the Priority Neurology Pipeline offers Chronic Neuropathic Pain, Prion Disease, and Neurology; Partnered Programs offer Hemophilia A, Oncology, ALS/FTD, and Huntington's Disease; and Other Pipelines include Fabry Disease, Renal Transplant, Inflammatory Bowel Disease, and Multiple Sclerosis.
About WALD Waldencast plc
Waldencast PLC is a beauty and wellness operating platform. The company is organized into two reportable segments namely Obagi Skincare and Milk Makeup. The company generates the majority of its revenue from the Obagi Medical segment. The Obagi Medical segment is engaged in developing, marketing, and selling skin health products. The Milk Makeup segment includes developing, marketing, and selling cosmetics, skincare, and other beauty products. Geographically the company generates the majority of its revenue from North America region.